Skip to search formSkip to main contentSkip to account menu

Fluphenazine

Known as: 2-(Trifluoromethyl)-10-(3-(1-(beta-hydroxyethyl)-4-piperazinyl)propyl)phenothiazine, Fluphenazine [Chemical/Ingredient], 1-Piperazineethanol, 4-(3-(2-(trifluoromethyl)-10H-phenothiazin-10-yl)propyl)-(9CI) 
A phenothiazine with antipsychotic activity. Fluphenazine exerts its actions by blocking postsynaptic dopamine D2 receptors in the limbic, cortical… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1990
1990
To the Editor.— It is well-known that schizophrenic inpatients do not always swallow their neuroleptic tablets. Default rates in… 
1985
1985
Summary Seven years after the completion of the original trial, over 73% of patients were maintained on depot neuroleptics, and… 
1984
1984
Plasma levels of fluphenazine and clinical response were examined in 19 inpatient schizophrenics (DSM-III diagnoses) using a… 
1982
1982
The radioreceptor assay for neuroleptics (NRRA) holds out great theoretical promise as a method for monitoring blood neuroleptic… 
Highly Cited
1981
Highly Cited
1981
Spinach (Spinacia oleracea, L.) cells in liquid culture release peroxidases. This release is reduced by EGTA and promoted by… 
Highly Cited
1979
Highly Cited
1979
During suckling, anaesthetized lactating rats release regular (about every 7 min) but brief pulses of oxytocin (0.5--1.0 mu… 
1978
1978
Intracellular recordings from neurones, receiving monosynaptic contacts from a dopamine-containing (DA-containing) neurone in the… 
1978
1978
We describe a method for quantitative determination of fluphenazine in human plasma, based on gas chromatography of its… 
1974
1974
Rats were treated chronically with increasing doses of trifluoperazine, prochlorperazine, fluphenazine, or perphenazine per os… 
1960
1960
Fluphenazine is a highly potent psychopharmacologic agent which is effective in controlling behavioral symptoms in chronic…